SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-18-001062
Filing Date
2018-02-14
Accepted
2018-02-14 10:37:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADAMAS PHARMACEUTICALS, INC. p18-0108sc13ga.htm SC 13G/A 69183
  Complete submission text file 0000902664-18-001062.txt   70795
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 18608538
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1140 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1140 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-554-5700
BOW STREET, LLC (Filed by) CIK: 0001578964 (see all company filings)

IRS No.: 244778332 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A